Literature DB >> 33374105

Gd/Y Hydroxide Nanosheets as Highly Efficient T1/T2 MRI Contrast Agents.

Xin Li1, Zhenhai Xue2, Jinfeng Xia2, Guohong Zhou2, Danyu Jiang2, Mengting Dai1, Wenhui Wang1, Jiayan Miu1, Yuerong Heng1, Cuiyan Yu1, Qiang Li1.   

Abstract

To develop highly efficient T1/T2 magnetic resonance imaging (MRI) contrast agents (CAs), Gd/Y hydroxide nanosheets were synthesized by a simple exfoliation method from layer compounds using sodium polyacrylate (PAA) as a dispersant and stabilizer. Transmission electron microscopy (TEM) and atomic force microscopy (AFM) results revealed the excellent performance of monolayer nanosheets with thicknesses of up to 1.5 nm. The MRI results of the T1 and T2 relaxation times showed that all of the Gd/Y hydroxide nanosheets have high longitudinal and transverse relaxivities (r1 and r2). In particular, the 10% Gd-LRH nanosheets exhibited excellent MRI performance (r1 = 103 mM-1 s-1, r2 = 372 mM-1 s-1), which is rarely reported. Based on the relationship between the structure of 10% Gd-LRH nanosheets and their MRI performances, and the highly efficient MRI of spaced Gd atoms in the nanosheets, a special model to explain the outstanding MRI performance of the 10% Gd-LRH nanosheets is suggested. The cytotoxicity assessment of the 10% Gd-LRH nanosheets, evaluated by CCK-8 assays on HeLa cells, indicated no significant cytotoxicity. This study presents a significant advancement in 2D nanomaterial MRI CA research, with Gd-doped nanosheets positioned as highly efficient T1/T2 MRI CA candidates.

Entities:  

Keywords:  Gd-doped nanosheets; MRI; PAA; dual-modal contrast agent

Year:  2020        PMID: 33374105     DOI: 10.3390/nano11010017

Source DB:  PubMed          Journal:  Nanomaterials (Basel)        ISSN: 2079-4991            Impact factor:   5.076


  1 in total

1.  Revisiting the factors influencing the magnetic resonance contrast of Gd2O3 nanoparticles.

Authors:  Yanyue Liu; Yingfan Dai; Haifeng Li; Dida Duosiken; Na Tang; Kang Sun; Ke Tao
Journal:  Nanoscale Adv       Date:  2021-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.